Recovering from Opioid Use? Join Our Study
Yale University researchers are partnering with individuals who are currently receiving methadone or buprenorphine treatment for a research study aimed at understanding the effectiveness of cannabinoids as an additional treatment option.
Conducted at VA Connecticut Healthcare System, West Haven, CT
currently receiving methadone or buprenorphine
18-70 Years Old
Fast Facts
Study Background
In 2019, nearly 50,000 people in the United States died from opioid-involved overdoses. The existing treatments for opioid use disorder (OUD) focus on preventing craving and withdrawal symptoms but do not fully address the risk for relapse.

Thus, researchers believe that there is a growing need to develop new treatment options for OUD. This research study explores the short-term effects of dronabinol, a synthetic form of delta-9-tetrahydrocannabinol (THC), the main ingredient of cannabis, among persons with OUD who are receiving treatment with methadone or buprenorphine.

VA Connecticut / Project ID 1583127
Yale HIC # 2000027065
Additional Information